Ausgabe 4/2013
Inhalt (16 Artikel)
- Multiple Myeloma (R Niesvizky, Section Editor)
Management of Double-Refractory Multiple Myeloma
Jason P. Meadows, Tomer M. Mark
- Multiple Myeloma (R Niesvizky, Section Editor)
Incorporating Novel Agents in the Management of Elderly Myeloma Patients
Tommasina Guglielmelli, Antonio Palumbo
- Multiple Myeloma (R Niesvizky, Section Editor)
New Approaches to Smoldering Myeloma
María-Victoria Mateos, Jesús F. San Miguel
- Multiple Myeloma (R Niesvizky, Section Editor)
Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
Jordan Schecter, Suzanne Lentzsch
- Multiple Myeloma (R Niesvizky, Section Editor)
Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: What Place, If Any?
Sergio Giralt, Guenther Koehne
- Multiple Myeloma (R Niesvizky, Section Editor)
New Insights and Modern Treatment of AL Amyloidosis
Chakra P. Chaulagain, Raymond L. Comenzo
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
Genetic Basis of MPN: Beyond JAK2-V617F
Nicole C. C. Them, Robert Kralovics
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
Are MPNs Vascular Diseases?
Guido Finazzi, Valerio De Stefano, Tiziano Barbui
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
Preclinical Models for Drug Selection in Myeloproliferative Neoplasms
Niccolò Bartalucci, Costanza Bogani, Alessandro M. Vannucchi
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
The New Landscape of Therapy for Myelofibrosis
Krisstina Gowin, Robyn Emanuel, Holly Geyer, Ruben A. Mesa
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
WHO Classification of Myeloproliferative Neoplasms (MPN): A Critical Update
Hans Michael Kvasnicka
- Myeloproliferative Disorders (JJ Kiladjian, Section Editor)
Molecular Classification of Myeloproliferative Neoplasms—Pros and Cons
Moosa Qureshi, Claire Harrison
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
There’s Risk, and Then There’s RISK: The Latest Clinical Prognostic Risk Stratification Models in Myelodysplastic Syndromes
Amer M. Zeidan, Rami S. Komrokji
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Standardizing the Initial Evaluation for Myelodysplastic Syndromes
Danielle Marshall, Gail J. Roboz
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
Febrile Neutropenia in Hematologic Malignancies
Michael K. Keng, Mikkael A. Sekeres
- Myelodysplastic Syndromes (M Sekeres, Section Editor)
When to Transplant MDS, and What to Do When Transplant Fails
Katja Sockel, Uwe Platzbecker
